Anti-Angiogenic/Vascular Effects of the mTOR Inhibitor Everolimus Are Not Detectable by FDG/FLT-PET.
Honer M, Ebenhan T, Allegrini PR, Ametamey SM, Becquet M, Cannet C, Lane HA, O'Reilly TM, Schubiger PA, Sticker-Jantscheff M, Stumm M, McSheehy PM.
Honer M, et al. Among authors: allegrini pr.
Transl Oncol. 2010 Aug 1;3(4):264-75. doi: 10.1593/tlo.10127.
Transl Oncol. 2010.
PMID: 20689768
Free PMC article.